GL1X · GenesisL1 explorer

Research workbench

Crystal structure of GSK3 beta (GSK3b) in complex with CD7.

Analyse Crystal structure of GSK3 beta (GSK3b) in complex with CD7. in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
8AV1
Type
protein
Length
702 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.15
Source
Homo sapiens
Molecule
Glycogen synthase kinase-3 beta
EC
2.7.11.26, 2.7.11.1
UniProt
P49841
Ligands
O9L, SO4
Pockets
11 · best druggability 0.83

Structure

x-ray diffraction · resolution 2.15 · 1 distinct chain · 34% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BGlycogen synthase kinase-3 beta (EC 2.7.11.26, 2.7.11.1)protein35134% helix, 20% strandP49841

Ligands and binding sites

  • O9L · 2-pyridin-3-yl-8-thiomorpholin-4-yl-[1,3]oxazolo[5,4-f]quinoxaline · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 7 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18230.830.8690EDO, O9L
23950.780.8741EDO, O9L
31830.480.7627empty
41350.450.7727empty
5790.440.8013empty

Interfaces

1 interface between chains.

  • A–B · 1143 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified (phosphorylation).

Compared structures

  • P49841 · AlphaFold monomer V2.0 prediction for glycogen synthase kinase-3 beta (P49841) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.